|
SMAD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.86880013872826E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.80590028778738E-10 |
| Normal-vs-Stage2 |
2.12450000000031E-05 |
| Normal-vs-Stage3 |
1.393660E-04 |
| Normal-vs-Stage4 |
3.230100E-02 |
| Stage1-vs-Stage2 |
6.806800E-01 |
| Stage1-vs-Stage3 |
8.723600E-01 |
| Stage1-vs-Stage4 |
9.575800E-01 |
| Stage2-vs-Stage3 |
8.186600E-01 |
| Stage2-vs-Stage4 |
8.506200E-01 |
| Stage3-vs-Stage4 |
9.668400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.62239954382937E-10 |
| Normal-vs-AfricanAmerican |
2.04580000051635E-07 |
| Normal-vs-Asian |
5.87459999999984E-05 |
| Caucasian-vs-AfricanAmerican |
9.793600E-01 |
| Caucasian-vs-Asian |
4.138800E-01 |
| AfricanAmerican-vs-Asian |
4.225800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.93569613063482E-11 |
| Normal-vs-Female |
9.979100E-04 |
| Male-vs-Female |
1.281560E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.360000E-04 |
| Normal-vs-Extreme_Weight |
4.24980051150214E-11 |
| Normal-vs-Obese |
1.99709999981756E-07 |
| Normal-vs-Extreme_Obese |
5.642200E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.410300E-02 |
| Normal_Weight-vs-Obese |
5.131200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.517400E-01 |
| Extreme_Weight-vs-Obese |
1.391390E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.269400E-01 |
| Obese-vs-Extreme_Obese |
5.792600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.404200E-02 |
| Normal-vs-Age(41-60Yrs) |
8.57170000534424E-08 |
| Normal-vs-Age(61-80Yrs) |
7.90110199488936E-11 |
| Normal-vs-Age(81-100Yrs) |
6.17830000049224E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.277600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.414400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.660760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.103030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.659000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.204400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.96419555567695E-11 |
| Normal-VS-Type2 PRCC |
1.13489999953309E-07 |
| Normal-VS-KIRP CIMP |
8.537000E-01 |
| Normal-VS-Unclassified PRCC |
2.642100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.676600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.982300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.282200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.689970E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.981600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.026300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.71740002406085E-09 |
| Normal-vs-N1 |
4.018800E-04 |
| Normal-vs-N2 |
4.413200E-01 |
| N0-vs-N1 |
3.084400E-01 |
| N0-vs-N2 |
6.926000E-01 |
| N1-vs-N2 |
8.122800E-01 |
|
|
